Substance use disorder (SUD) treatment providers who prescribe medications for opioid use disorder (MOUD) via telehealth have received some good news. The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced a final rule that allows clinicians to prescribe buprenorphine via telehealth or audio-only telehealth visits for up to six months. This rule, called the Expansion of Buprenorphine Treatment via Telemedicine Encounter, is finalized and published in the Federal Register. While the new rule could make it easier for virtual prescribing, many providers are worried that ambiguity in the regulations would complicate the legal landscape for MOUD prescribing in the future.
Read the full article: DEA Releases Special Registration Framework, Telehealth Final Rule //
Source: https://bhbusiness.com/2025/01/15/dea-releases-special-registration-framework-telehealth-final-rule